Role of ING4 in human melanoma cell migration, invasion and patient survival

被引:98
作者
Li, Jun [1 ]
Martinka, Magdalena [2 ]
Li, Gang [1 ]
机构
[1] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC V6H 3Z6, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
D O I
10.1093/carcin/bgn086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inhibitor of growth (ING) 4 has been reported as a tumor suppressor and shown to diminish colony-forming efficiency, induce p53-dependent apoptosis and arrest cell cycle at G(2)-M phase. In this study, we investigated the role of ING4 in human melanoma pathogenesis. Using the tissue microarray technology, we found that ING4 expression is significantly decreased in malignant melanoma compared with dysplastic nevi (P < 0.0001, chi(2) test) and reduced ING4 staining is associated with melanoma thickness, ulceration (P = 0.034 and 0.002, respectively, chi(2) test) as well as poor overall and disease-specific 5-year survival of primary melanoma patients (P = 0.0002 and 0.001, respectively, chi(2) test). Cox regression analysis revealed that reduced ING4 staining is an independent factor for the poor prognosis of patients with primary melanomas. Furthermore, we found that overexpression of ING4 suppressed cell migration by 63% and inhibited the activity of Ras homolog gene family member A (RhoA) small GTPase protein and Rho-associated kinase (ROCK)-mediated formation of stress fiber in melanoma cells. Moreover, our data showed that overexpression of ING4 inhibited melanoma cell invasion by 43% compared with the control (P = 0.006, t-test) and ING4-overexpressing melanoma cells showed significantly reduced activity of matrix metalloproteinase (MMP)-2 and MMP-9. Taken together, this study highlights the importance of ING4 in melanoma pathogenesis and ING4 may serve as a promising prognostic marker and a potential therapeutic target for human melanoma.
引用
收藏
页码:1373 / 1379
页数:7
相关论文
共 43 条
[1]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[2]   Radiation therapy for malignant melanoma [J].
Ballo, MT ;
Ang, KK .
SURGICAL CLINICS OF NORTH AMERICA, 2003, 83 (02) :323-+
[3]   Involvement of Rd/nuclear factor-κB transcription factors in keratinocyte senescence [J].
Bernard, D ;
Gosselin, K ;
Monte, D ;
Vercamer, C ;
Bouali, F ;
Pourtier, A ;
Vandenbunder, B ;
Abbadie, C .
CANCER RESEARCH, 2004, 64 (02) :472-481
[4]   Oncogene-induced senescence: Putting the brakes on tumor development [J].
Braig, M ;
Schmitt, CA .
CANCER RESEARCH, 2006, 66 (06) :2881-2884
[5]  
Campos EI, 2004, INT J ONCOL, V25, P73
[6]   Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[7]   P33ING1 enhances UVB-induced apoptosis in melanoma cells [J].
Cheung, KJ ;
Li, G .
EXPERIMENTAL CELL RESEARCH, 2002, 279 (02) :291-298
[8]  
Cheung KJ, 2001, CANCER RES, V61, P4974
[9]   The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells [J].
Chin, MY ;
Ng, KCP ;
Li, G .
EXPERIMENTAL CELL RESEARCH, 2005, 304 (02) :531-543
[10]   Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases [J].
Dai, DL ;
Martinka, M ;
Li, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1473-1482